Dynamic Advisor Solutions LLC bought a new stake in shares of Waters Co. (NYSE:WAT - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 10,881 shares of the medical instruments supplier's stock, valued at approximately $4,010,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. Aster Capital Management DIFC Ltd purchased a new position in Waters during the 4th quarter valued at about $28,000. Bank of Jackson Hole Trust purchased a new stake in Waters in the fourth quarter worth $34,000. Steward Partners Investment Advisory LLC boosted its holdings in Waters by 129.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after acquiring an additional 53 shares in the last quarter. Whipplewood Advisors LLC increased its position in Waters by 5,200.0% during the 1st quarter. Whipplewood Advisors LLC now owns 106 shares of the medical instruments supplier's stock valued at $39,000 after purchasing an additional 104 shares during the period. Finally, Murphy & Mullick Capital Management Corp bought a new position in Waters in the fourth quarter worth about $42,000. 94.01% of the stock is currently owned by institutional investors.
Waters Stock Performance
WAT traded up $5.54 during midday trading on Monday, hitting $347.84. 294,903 shares of the company traded hands, compared to its average volume of 511,522. The company's 50-day moving average is $342.72 and its 200 day moving average is $367.75. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56. The firm has a market capitalization of $20.70 billion, a PE ratio of 32.48, a price-to-earnings-growth ratio of 3.79 and a beta of 1.11. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14.
Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Tuesday, May 6th. The medical instruments supplier reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.22 by $0.03. The company had revenue of $661.71 million for the quarter, compared to analysts' expectations of $655.50 million. Waters had a net margin of 21.56% and a return on equity of 46.31%. The firm's quarterly revenue was up 3.9% on a year-over-year basis. During the same quarter last year, the company posted $2.21 earnings per share. On average, research analysts expect that Waters Co. will post 12.86 EPS for the current year.
Wall Street Analyst Weigh In
Several equities research analysts recently weighed in on the company. UBS Group dropped their price target on Waters from $415.00 to $360.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 7th. JPMorgan Chase & Co. boosted their price objective on shares of Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a research note on Thursday, March 6th. Barclays decreased their target price on shares of Waters from $400.00 to $350.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. KeyCorp raised Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 price target on the stock in a research report on Monday, March 31st. Finally, Wall Street Zen lowered Waters from a "buy" rating to a "hold" rating in a research report on Saturday, June 7th. Ten research analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, Waters has a consensus rating of "Moderate Buy" and an average price target of $390.19.
Check Out Our Latest Research Report on Waters
About Waters
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Articles
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
